argenx SE operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares argenx SE with three other
miscellaneous service companies in Europe:
of UNITED KINGDOM
sales of £68.26 million [US$84.47 million]
Innate Pharma S.A.
(68.97 million Euros [US$75.63 million]
based in GERMANY
(71.76 million Euros [US$78.68 million]
of which 52%
was Partnered Discovery).
Sales increased substantially in 2019:
argenx SE reported sales of 69.78 million Euro (US$76.52 million)
December of 2019.
increase of 224.8%
versus 2018, when the company's sales were 21.48 million Euro.